Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.2K Buy
197
+123
+166% +$30.7K ﹤0.01% 1149
2025
Q4
$17.8K Sell
74
-8
-10% -$2.05K ﹤0.01% 1486
2025
Q3
$22.4K Sell
82
-8
-9% -$2.19K ﹤0.01% 1402
2025
Q2
$23.2K Sell
90
-32
-26% -$7.63K ﹤0.01% 1360
2025
Q1
$27.3K Sell
122
-171
-58% -$39.9K ﹤0.01% 1214
2024
Q4
$67K Buy
+293
New +$70.5K ﹤0.01% 887

Other funds holding RMD

SBI Securities's RMD Position: Q1 2026 in Review

SBI Securities increased its ResMed (RMD) stake by 166% in Q1 2026, buying an estimated $30.7K and bringing the position to 197 shares worth $44.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

SBI Securities first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $67K in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • SBI Securities held 197 shares of ResMed worth $44.2K as of Q1 2026.
  • SBI Securities bought 123 ResMed shares in Q1 2026, an estimated $30.7K.
  • ResMed made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1149 holding.
  • SBI Securities first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's ResMed position peaked at $67K in Q4 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.